Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
10.25
+0.29 (2.96%)
At close: Jun 6, 2025, 4:00 PM
9.82
-0.42 (-4.15%)
After-hours: Jun 6, 2025, 7:09 PM EDT
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$727,457
Profits / Employee
-$148,319
Market Cap
1.23B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
DVAX News
- 2 days ago - Dynavax Comments on Glass Lewis Recommendation - PRNewsWire
- 2 days ago - Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies - Business Wire
- 9 days ago - Dynavax to Present at William Blair's 45th Annual Growth Stock Conference - PRNewsWire
- 14 days ago - Deep Track Capital Comments on ISS Recommendation - Business Wire
- 14 days ago - ISS backs Dynavax directors in board fight with Deep Track Capital - Reuters
- 14 days ago - Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees - PRNewsWire
- 16 days ago - Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good - Seeking Alpha
- 22 days ago - Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting - Business Wire